Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse

Open Access

Peer-reviewed

Research Article

Richard G. Peterson ,

* E-mail: rpeterson@crownbio.com

Affiliation Crown Bioscience - Indiana, Indianapolis, Indiana, United States of America

http://orcid.org/0000-0003-2123-5813

⨯
Charles Van Jackson,

Affiliation Crown Bioscience - Indiana, Indianapolis, Indiana, United States of America
⨯
Karen M. Zimmerman,

Affiliation Crown Bioscience - Indiana, Indianapolis, Indiana, United States of America
⨯
Jorge Alsina-Fernandez,

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯
M. Dodson Michael,

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯
Paul J. Emmerson,

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯
Tamer Coskun

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯

Reader Comments (0)

Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Obesity
Is the Subject Area "Obesity" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Leptin
Is the Subject Area "Leptin" applicable to this article?

Thanks for your feedback.
Body weight
Is the Subject Area "Body weight" applicable to this article?

Thanks for your feedback.
Insulin resistance
Is the Subject Area "Insulin resistance" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.